Evaluating Pharmacists’ Pharmacological Knowledge and Views Regarding Pfizer-BioNTech COVID-19 Vaccine in Saudi Arabia

References

• Johns Hopkins Coronavirus Resource Center. COVID-19 map. Available from:https://pubmed.ncbi.nlm.nih.gov/11167664/. Accessed June 26, 2021.
   Google Scholar
• Carfì A, Bernabei R, Landi F. persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–605. doi:10.1001/jama.2020.12603
   PubMed Web of Science ®Google Scholar
• Disser NP, De Micheli AJ, Schonk MM, et al. Musculoskeletal consequences of COVID-19. J Bone Joint Surg Am. 2020;102(14):1197–1204. doi:10.2106/JBJS.20.00847
   PubMed Web of Science ®Google Scholar
• Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020;8(12):1201–1208. doi:10.1016/S2213-2600(20)30370-2
   PubMed Web of Science ®Google Scholar
• Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. doi:10.1016/j.ijantimicag.2020.105924
   PubMed Web of Science ®Google Scholar
• Riad A, Klugar M, Krsek M. COVID-19-related oral manifestations: early disease features? Oral Dis. 2020.doi:10.1111/odi.13516
   Web of Science ®Google Scholar
• Riad A, Kassem I, Hockova B, Badrah M, Klugar M. Tongue ulcers associated with SARS-CoV-2 infection: a case series. Oral Dis. 2020.doi:10.1111/odi.13635
   Web of Science ®Google Scholar
• Hocková B, Riad A, Valky J, et al. Oral complications of ICU patients with COVID-19: case-series and review of two hundred ten cases. J Clin Med. 2021;10(4):581. doi:10.3390/jcm10040581
   PubMed Web of Science ®Google Scholar
• Marks M, Millat-Martinez P, Ouchi D, et al. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study. Lancet Infect Dis. 2021;21(5):629–636. doi:10.1016/S1473-3099(20)30985-3
   PubMed Web of Science ®Google Scholar
• World Health Organization. Coronavirus disease (COVID-19). Available from:https://www.who.int/healthtopics/coronavirus#tab=tab_1. Accessed June 26, 2021.
   Google Scholar
• Noushad M, Nassani MZ, Alsalhani AB, et al. COVID-19 vaccine intention among healthcare workers in Saudi Arabia: a cross-sectional survey. Vaccines. 2021;9(8):835.
   Web of Science ®Google Scholar
• Sahin U, Muik A, Derhovanessian E, et al. COVID-19 vaccine BNT162b1 elicits human antibody and T(H)1 T cell responses. Nature. 2020;586(7830):594–599. doi:10.1038/s41586-020-2814-7
   PubMed Web of Science ®Google Scholar
• Mahase E. Covid-19: vaccine candidate may be more than 90% effective, interim results indicate. BMJ. 2020;371:m4347. doi:10.1136/bmj.m4347
   PubMed Web of Science ®Google Scholar
• Mulligan MJ, Lyke KE, Kitchin N, et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020;586(7830):589–593. doi:10.1038/s41586-020-2639-4
   PubMed Web of Science ®Google Scholar
• Pilkington EH, Suys EJA, Trevaskis NL, et al. From influenza to COVID-19: lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases. Acta Biomater. 2021;131:16–40. doi:10.1016/j.actbio.2021.06.023
   PubMed Web of Science ®Google Scholar
• CDC COVID-19 Response Team, Food and Drug Administration. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine - United States, December 14–23, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(2):46–51. doi:10.15585/mmwr.mm7002e1
   PubMed Web of Science ®Google Scholar
• Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa2034577
   PubMed Web of Science ®Google Scholar
• Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021;373:n1088. doi:10.1136/bmj.n1088
   PubMed Web of Science ®Google Scholar
• Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna vaccines. Eur Rev Med Pharmacol Sci. 2021;25(3):1663–1669. doi:10.26355/eurrev_202102_24877
   PubMed Web of Science ®Google Scholar
• Pfizer. Coronavirus facts, news & information. Available from: https://www.pfizer.com/science/coronavirus/resources. Accessed February 16, 2021.
   Google Scholar
• Riad A, Hocková B, Kantorová L, et al. Side effects of mRNA-based COVID-19 vaccine: nationwide phase IV study among healthcare workers in Slovakia. Pharmaceuticals. 2021;14(9):873. doi:10.3390/ph14090873
   Web of Science ®Google Scholar
• Riad A, Pokorná A, Attia S, Klugarová J, Koščík M, Klugar M. Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. J Clin Med. 2021;10(7):1428. doi:10.3390/jcm10071428
   PubMed Web of Science ®Google Scholar
• Riad A, Pokorná A, Klugarová J, et al. Side effects of mRNA-based COVID-19 vaccines among young adults (18–30 years old): an independent post-marketing study. Pharmaceuticals. 2021;14(10):1049. doi:10.3390/ph14101049
   Web of Science ®Google Scholar
• Ministry of Health. Various topics: COVID-19. Available from: https://www.moh.gov.sa/en/AwarenessFigureform/VariousTopics/Pages/COIVD-19.aspx. Accessed June 26, 2021.
   Google Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening The Reporting Of Observational Studies In Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–1499. doi:10.1016/j.ijsu.2014.07.013
   PubMed Web of Science ®Google Scholar
• Al Arifi MN. Evaluation of knowledge of Alzheimer disease among health university students in Riyadh, Saudi Arabia. Saudi Pharm J. 2020;28(8):911–915. doi:10.1016/j.jsps.2020.06.011
   PubMed Web of Science ®Google Scholar
• Al-Marshoudi S, Al-Balushi H, Al-Wahaibi A, et al. Knowledge, Attitudes, and Practices (KAP) toward the COVID-19 vaccine in Oman: a pre-campaign cross-sectional study. Vaccines. 2021;9(6). doi:10.3390/vaccines9060602
   Web of Science ®Google Scholar
• Ataş O, Talo Yildirim T. Evaluation of knowledge, attitudes, and clinical education of dental students about COVID-19 pandemic. PeerJ. 2020;8:e9575. doi:10.7717/peerj.9575
   PubMed Web of Science ®Google Scholar
• Dreher A, Pietrowsky R, Loerbroks A. Pandemic-related attitudes, stressors and work outcomes among medical assistants during the SARS-CoV-2 (“Coronavirus”) pandemic in Germany: a cross-sectional study. PLoS One. 2021;16(1):e0245473. doi:10.1371/journal.pone.0245473
   PubMed Web of Science ®Google Scholar
• Green CF, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol. 2001;51(1):81–86. doi:10.1046/j.1365-2125.2001.01306.x
   PubMed Web of Science ®Google Scholar
• Kara E, Demirkan K, Ünal S. Knowledge and attitudes among hospital pharmacists about COVID-19. Turk J Pharm Sci. 2020;17(3):242–248. doi:10.4274/tjps.galenos.2020.72325
   PubMed Web of Science ®Google Scholar
• Basheti IA, Nassar R, Barakat M, et al. Pharmacists’ readiness to deal with the coronavirus pandemic: assessing awareness and perception of roles. Res Social Adm Pharm. 2021;17(3):514–522. doi:10.1016/j.sapharm.2020.04.020
   PubMed Web of Science ®Google Scholar
• Bukhari N, Rasheed H, Nayyer B. Pharmacists at the frontline beating the COVID-19 pandemic. J Pharma Policy Pract. 2020;13(1):8. doi:10.1186/s40545-020-00210-w
   PubMedGoogle Scholar
• Falconer N, Monaghan C, Snoswell CL. The pharmacist informatician: providing an innovative model of care during the COVID-19 crisis. Int J Pharm Pract. 2021;29(2):152–156. doi:10.1093/ijpp/riaa017
   PubMed Web of Science ®Google Scholar
• Merks P, Jakubowska M, Drelich E, et al. The legal extension of the role of pharmacists in light of the COVID-19 global pandemic. Res Social Adm Pharm. 2021;17(1):1807–1812. doi:10.1016/j.sapharm.2020.05.033
   PubMed Web of Science ®Google Scholar
• Moreau C. The pharmacist as part of the primary care team during the COVID-19 pandemic. J Am Board Fam Med. 2021;34(Suppl):S21–s25. doi:10.3122/jabfm.2021.S1.200180
   PubMed Web of Science ®Google Scholar
• Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9(2):160.
   PubMed Web of Science ®Google Scholar
• Li Q, Norman S, Guthrie P, et al. Strategies used to meet the challenges of mass COVID-19 vaccination by the pharmacy department in a large academic medical center. Am J Health Syst Pharm. 2021;78(18):1724–1731. doi:10.1093/ajhp/zxab184
   PubMed Web of Science ®Google Scholar
• Riad A, Abdulqader H, Morgado M, et al. Global prevalence and drivers of dental students’ COVID-19 vaccine hesitancy. Vaccines. 2021;9(6):556.
   Web of Science ®Google Scholar